BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 7511928)

  • 1. CD44 isoform expression mediated by alternative splicing: tissue-specific regulation in mice.
    Hirano H; Screaton GR; Bell MV; Jackson DG; Bell JI; Hodes RJ
    Int Immunol; 1994 Jan; 6(1):49-59. PubMed ID: 7511928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of alternatively spliced forms of the CD44 extracellular-matrix receptor on human lung carcinomas.
    Jackson DG; Schenker T; Waibel R; Bell JI; Stahel RA
    Int J Cancer Suppl; 1994; 8():110-5. PubMed ID: 7515025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.
    Jackson DG; Bell JI; Dickinson R; Timans J; Shields J; Whittle N
    J Cell Biol; 1995 Feb; 128(4):673-85. PubMed ID: 7532175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adhesive interactions between alternatively spliced CD44 isoforms.
    Droll A; Dougherty ST; Chiu RK; Dirks JF; McBride WH; Cooper DL; Dougherty GJ
    J Biol Chem; 1995 May; 270(19):11567-73. PubMed ID: 7538117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD44 variant transcripts in dog lymphatic tissue.
    Milde KF; Alejandro R; Pastori RL
    Immunogenetics; 1994; 40(6):437-44. PubMed ID: 7525471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor.
    Bennett KL; Jackson DG; Simon JC; Tanczos E; Peach R; Modrell B; Stamenkovic I; Plowman G; Aruffo A
    J Cell Biol; 1995 Feb; 128(4):687-98. PubMed ID: 7532176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative splicing of CD44 pre-mRNA in human colorectal tumors.
    Finn L; Dougherty G; Finley G; Meisler A; Becich M; Cooper DL
    Biochem Biophys Res Commun; 1994 Apr; 200(2):1015-22. PubMed ID: 7513991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of growth and dissemination of a human lymphoma by CD44 splice variants.
    Bartolazzi A; Jackson D; Bennett K; Aruffo A; Dickinson R; Shields J; Whittle N; Stamenkovic I
    J Cell Sci; 1995 Apr; 108 ( Pt 4)():1723-33. PubMed ID: 7542258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 isoforms during differentiation and development.
    Ruiz P; Schwärzler C; Günthert U
    Bioessays; 1995 Jan; 17(1):17-24. PubMed ID: 7535522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies.
    Salles G; Zain M; Jiang WM; Boussiotis VA; Shipp MA
    Blood; 1993 Dec; 82(12):3539-47. PubMed ID: 7505117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 in differentiated embryonic stem cells: surface expression and transcripts encoding multiple variants.
    Haegel H; Dierich A; Ceredig R
    Dev Immunol; 1994; 3(4):239-46. PubMed ID: 7542511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A PCR-based method for the analysis of human CD44 splice products.
    van Weering DH; Baas PD; Bos JL
    PCR Methods Appl; 1993 Oct; 3(2):100-6. PubMed ID: 7505677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 is the major peanut lectin-binding glycoprotein of human epidermal keratinocytes and plays a role in intercellular adhesion.
    Hudson DL; Sleeman J; Watt FM
    J Cell Sci; 1995 May; 108 ( Pt 5)():1959-70. PubMed ID: 7544799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer.
    Dall P; Heider KH; Sinn HP; Skroch-Angel P; Adolf G; Kaufmann M; Herrlich P; Ponta H
    Int J Cancer; 1995 Feb; 60(4):471-7. PubMed ID: 7530237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of two isoforms of CD44 in human endometrium.
    Behzad F; Seif MW; Campbell S; Aplin JD
    Biol Reprod; 1994 Oct; 51(4):739-47. PubMed ID: 7529574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of expression of CD44 isoforms and E-cadherin with differentiation in human urothelial cell lines and transitional cell carcinoma.
    Hong RL; Pu YS; Chu JS; Lee WJ; Chen YC; Wu CW
    Cancer Lett; 1995 Feb; 89(1):81-7. PubMed ID: 7533658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.
    Screaton GR; Bell MV; Jackson DG; Cornelis FB; Gerth U; Bell JI
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12160-4. PubMed ID: 1465456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel variants of CD44 arising from alternative splicing: changes in the CD44 alternative splicing pattern of MCF-7 breast carcinoma cells treated with hyaluronidase.
    Tanabe KK; Nishi T; Saya H
    Mol Carcinog; 1993; 7(4):212-20. PubMed ID: 8352881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor.
    Stauder R; Eisterer W; Thaler J; Günthert U
    Blood; 1995 May; 85(10):2885-99. PubMed ID: 7537983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44 isoform expression in periodontal tissues: cell-type specific regulation of alternative splicing.
    Hirano F; Hirano H; Hino E; Takayama S; Saito K; Kusumoto Y; Shimabukuro Y; Murakami S; Okada H
    J Periodontal Res; 1997 Nov; 32(8):634-45. PubMed ID: 9409458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.